CoChat

CD103 is a hallmark of tumor‐infiltrating regulatory T cells

Anz, David, Mueller, Wolfgang, Golic, Michaela, Kunz, Wolfgang G., Rapp, Moritz, Koelzer, Viktor H., Ellermeier, Jonathan, Ellwart, Joachim W., Schnurr, Max, Bourquin, Carole, Endres, Stefan · 2011 · International Journal of Cancer
Cited by 116

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Regulatory T cells (Treg) mediate tolerance towards self‐antigens by suppression of innate and adaptive immunity. In cancer patients, tumor‐infiltrating FoxP3+ Treg suppress local anti‐tumor immune responses and are often associated with poor prognosis. Markers that are selectively expressed on tumor‐infiltrating Treg may serve as targets for immunotherapy of cancer. Here we show that CD103, an integrin mediating lymphocyte retention in epithelial tissues, is expressed at high levels on tumor‐infiltrating FoxP3+ Treg in several types of murine cancer. In the CT26 model of colon cancer up to 90% of the intratumoral FoxP3+ cells expressed CD103 compared to less than 20% in lymphoid organs. CD103+ Treg suppressed T effector cell activation more strongly than CD103 neg Treg. Expression of CD103 on Treg closely correlated with intratumoral levels of transforming growth factor β (TGF‐β) and could be induced in a TGF‐β‐dependent manner by tumor cell lines. In vivo, gene silencing of TGF‐β reduced the frequency of CD103+ Treg, demonstrating that CD103 expression on tumor‐infiltrating Treg is driven by intratumoral TGF‐β. Functional blockade of CD103 using a monoclonal antibody did however not reduce the number of intratumoral Treg, indicating that CD103 is not involved in homing or retention of FoxP3+ cells in the tumor tissue. In conclusion, expression of CD103 is a hallmark of Treg that infiltrate TGF‐β‐secreting tumors. CD103 thus represents an interesting target for selective depletion of tumor‐infiltrating Treg, a strategy that may help to improve anti‐cancer therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.25902

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 116

Metadata

Authors
Anz, D., Mueller, W., Golic, M., Kunz, W. G., Rapp, M., Koelzer, V. H., Ellermeier, J., Ellwart, J. W., Schnurr, M., Bourquin, C., & Endres, S.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2011-04
Volume
129
Issue
10
Pages
2417-2426
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W1999999047
Cited by
116
References
7
FWCI
2.95
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CD103 is a hallmark of tumor‐infiltrating regulatory T cells. https://app.cochat.ai/papers/10.1002/ijc.25902
The paper
Anz, D., Mueller, W., Golic, M., Kunz, W. G., Rapp, M., Koelzer, V. H., Ellermeier, J., Ellwart, J. W., Schnurr, M., Bourquin, C., & Endres, S. (2011). CD103 is a hallmark of tumor‐infiltrating regulatory T cells. International Journal of Cancer. https://doi.org/10.1002/ijc.25902

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.